KPV: Best Telehealth Providers for Healing & Tissue Regeneration (2026)
A tripeptide fragment derived from the C-terminus of alpha-melanocyte-stimulating hormone (α-MSH). KPV carries the anti-inflammatory properties of α-MSH without its melanogenic effects, making it a targeted tool for gut and systemic inflammation.
Reviewed by Dr. James Okafor, PharmDPharmDKPV at a Glance
Category
Healing & Tissue Regeneration
Administration
Oral capsule or subcutaneous injection
Telehealth Providers
3 compared
Price Range
$130 – $170/mo
Typical Dose
250-500mcg (SQ) or as oral capsule
Frequency
Once daily
Protocol Duration
4-8 weeks
Prescription
Required
Research highlight: KPV directly inhibits NF-κB signaling — the master transcription factor driving inflammatory cytokine production — in gut epithelium, providing targeted anti-inflammatory action without the melanocyte-stimulating effects of its parent peptide α-MSH.
What is KPV Used For?
Also known as: Lys-Pro-Val, Alpha-MSH tripeptide
- Gut inflammation
- IBD and Crohn's support
- Wound healing
- Systemic anti-inflammatory
How KPV Works
KPV is a tripeptide (Lys-Pro-Val) representing the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). α-MSH itself has potent anti-inflammatory properties, but its full peptide structure also stimulates skin pigmentation and other effects. KPV preserves the anti-inflammatory activity of α-MSH through direct inhibition of NF-κB signaling — the master transcription factor driving inflammatory cytokine production — without the melanocyte-stimulating effects. It is particularly effective in the gut where intestinal epithelial cells express both MC1R and the receptors responsive to KPV.
KPVDosing & Administration
| Typical Dose | 250-500mcg (SQ) or as oral capsule |
| Frequency | Once daily |
| Protocol Duration | 4-8 weeks |
| Route | Oral capsule or subcutaneous injection |
Dosing information is for educational purposes only. Your prescribing physician will determine the appropriate dose based on your medical history and treatment goals.
What to Expect from KPV
For inflammatory gut conditions (IBD, Crohn's, leaky gut), oral KPV capsules produce local anti-inflammatory effects in the intestinal mucosa within 2–4 weeks of daily use. Systemic anti-inflammatory effects from subcutaneous injection may be noticed within 1–3 weeks. The therapeutic endpoint varies significantly by condition severity.
Who Should Consider KPV?
- Inflammatory bowel disease (IBD) and Crohn's disease
- Leaky gut and intestinal permeability issues
- Systemic inflammation conditions
- Patients seeking gut-targeted anti-inflammatory therapy
KPV Side Effects
- Oral: generally very well-tolerated
- Subcutaneous: mild injection site reactions
- No significant adverse effects reported in current research
This is not a complete list of side effects. Always consult your prescribing physician before starting KPV.
3 Telehealth Providers Offering KPV
Sorted by lowest price. All providers require a prescription from a licensed physician.
| Provider | Price | Dose | Rating | Consultation | Lab Testing |
|---|---|---|---|---|---|
| Defy Medical Tampa, FL | $130/monthly | Standard protocol | 4.1/5 | Video Telehealth | Included |
| Evolve Telemed San Diego, CA | $145/monthly | Standard protocol | 4.0/5 | Video Telehealth | Included |
| TruLife Health Scottsdale, AZ | $170/monthly | Standard protocol | 4.1/5 | Video Telehealth | Included |
How to Choose the Best Telehealth Provider for Healing Peptides
Healing peptide protocols require clinical precision. These are the criteria that separate excellent providers from those cutting corners.
Injury-Specific Protocol Design
The best providers tailor peptide selection, dosing, and stacking to your specific injury type — gut healing, tendon repair, and post-surgical recovery each require different approaches.
503A/503B Pharmacy Sourcing
Healing peptides like BPC-157 and TB-500 must come from FDA-registered compounding pharmacies. Verify your provider uses a licensed 503A or 503B facility — product quality directly affects outcomes.
Imaging and Diagnostics Integration
Providers who request imaging (MRI, ultrasound) or lab work before prescribing can make better-informed decisions about protocol design, dosing, and duration.
Progress Monitoring
Healing protocols should include structured follow-ups to assess tissue response, adjust dosing, and decide when to cycle off. Providers who prescribe without follow-up leave outcomes to chance.
Stacking Expertise
Many healing peptides work synergistically (BPC-157 + TB-500, KPV + BPC-157 for gut). Providers experienced with peptide stacking can design protocols that address multiple healing pathways simultaneously.
Regulatory Awareness
FDA restrictions on certain peptides (BPC-157 bulk compounding) mean availability shifts. The best providers stay current and offer compliant alternatives (Pentadeca Arginate) when needed.
Frequently Asked Questions About KPV
How does KPV compare to BPC-157 for gut healing?
KPV and BPC-157 work through complementary mechanisms: KPV directly inhibits NF-κB inflammatory signaling in gut epithelium, while BPC-157 promotes angiogenesis and growth factor signaling for structural repair. For IBD, Crohn's, or leaky gut, stacking both is common — BPC-157 for structural repair and KPV for inflammatory suppression.
Can KPV be taken orally?
Yes — unlike larger peptides that are degraded by stomach acid, KPV's small tripeptide structure allows meaningful oral bioavailability to the gut. Oral capsules are preferred for intestinal targeting (IBD, Crohn's), while subcutaneous injection is used for systemic anti-inflammatory effects.
Is KPV useful for skin conditions?
Yes. α-MSH (KPV's parent peptide) is known to reduce skin inflammation, and KPV has shown anti-inflammatory effects in skin models. Topical and injectable KPV is used by some providers for inflammatory skin conditions, wound healing, and rosacea, though human clinical trial data is still limited.
Is KPV related to Pentadeca Arginate (PDA)?
No — they are structurally different peptides with different mechanisms. PDA is derived from the BPC-157 sequence and is used as an alternative to BPC-157 post-FDA restrictions. KPV is derived from α-MSH and works primarily through NF-κB inhibition. They can complement each other in gut healing protocols.
KPV Alternatives for Healing & Tissue Regeneration
Compare other healing & tissue regeneration peptides available through telehealth.
BPC-157
A synthetic peptide derived from a protective protein found in human gastric juice. Widely studied for its regenerative properties on tendons, ligaments, muscles, and the gut lining.
GHK-Cu
A naturally occurring copper-binding peptide found in human plasma. Declines with age and is used therapeutically for skin rejuvenation, wound healing, and anti-inflammatory effects.
LL-37
The only known human cathelicidin antimicrobial peptide, naturally produced by immune cells and epithelial tissues. LL-37 has broad-spectrum antimicrobial activity alongside potent immunomodulatory and wound-healing properties.
Pentadeca Arginate
A stable arginate salt form of a 15-amino-acid sequence related to BPC-157. Developed as a compounding-pharmacy-compatible alternative following FDA regulatory pressure on BPC-157. Offers similar regenerative and anti-inflammatory benefits through overlapping pathways.
TB-500
A synthetic fragment of thymosin beta-4, a naturally occurring peptide involved in tissue repair and regeneration. Studied for its ability to promote healing of muscles, tendons, ligaments, and skin.